HIGHLIGHTS
- who: Xiaojun Luo and colleagues from the Hepatic Biliary and Pancreatic Cancer Center, Chongqing University Cancer Hospital, Chongqing, China have published the research: The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma, in the Journal: Journal of Oncology of 29/08/2022
- what: The aim of this investigation was to examine the potential usefulness of lncRNA DDX11 antisense RNA 1 (DDX11-AS1) as a biomarker for diagnosis and prognosis in hepatocellular carcinoma (HCC). The authors aimed to explore the potential of DDX11-AS1 used . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.